Basics of Immunotherapy with Dr. Charles Drake – NYC Immunotherapy Patient Summit 2018
Charles Drake, M.D., Ph.D., of NewYork-Presbyterian/Columbia University Medical Center, provides a 20-minute introduction to the basics of immunotherapy, using the immune system to fight cancer, at the 2018 Immunotherapy Patient Summit in New York City. cancerresearch.org/summit
Dr. Charles Drake covers checkpoint inhibitor therapy, CAR T cell therapy, oncolytic virus therapy, and therapeutic cancer vaccines.
Cancer Research Institute Immunotherapy Patient Summits are free half-day Saturday events that provide a forum for patients, caregivers, and advocates to meet together along with scientific and healthcare experts to learn more about how new breakthroughs in immunotherapy are changing standards of care for all cancers. In 2018, the Immunotherapy Patient Summit series visits San Francisco, New York City, San Diego, and Houston. The New York City summit was live streamed online. This video is a recording of the live stream. cancerresearch.org/summit
(c) Cancer Research Institute 2018
Видео Basics of Immunotherapy with Dr. Charles Drake – NYC Immunotherapy Patient Summit 2018 канала Cancer Research Institute
Dr. Charles Drake covers checkpoint inhibitor therapy, CAR T cell therapy, oncolytic virus therapy, and therapeutic cancer vaccines.
Cancer Research Institute Immunotherapy Patient Summits are free half-day Saturday events that provide a forum for patients, caregivers, and advocates to meet together along with scientific and healthcare experts to learn more about how new breakthroughs in immunotherapy are changing standards of care for all cancers. In 2018, the Immunotherapy Patient Summit series visits San Francisco, New York City, San Diego, and Houston. The New York City summit was live streamed online. This video is a recording of the live stream. cancerresearch.org/summit
(c) Cancer Research Institute 2018
Видео Basics of Immunotherapy with Dr. Charles Drake – NYC Immunotherapy Patient Summit 2018 канала Cancer Research Institute
Показать
Комментарии отсутствуют
Информация о видео
11 октября 2018 г. 22:18:07
00:16:22
Другие видео канала
![What Cancer Patients Should Know: Latest Immunotherapy News from ASCO 2018](https://i.ytimg.com/vi/OkaS6ZkPml0/default.jpg)
![Updates in Multiple Myeloma from ASCO 2020](https://i.ytimg.com/vi/xQ2ZXlNhUr8/default.jpg)
![Scientists May Have Found a Way to Treat All Cancers... By Accident | SciShow News](https://i.ytimg.com/vi/e-V_MDVgISo/default.jpg)
![Nature | Cancer Immunotherapy - medical animation](https://i.ytimg.com/vi/-9q4c-QRdes/default.jpg)
![PVCs, Cardiomyopathies and Sudden Death (William G. Stevenson, MD) September 30, 2021](https://i.ytimg.com/vi/LWVbreWvOtM/default.jpg)
![What is Acceptance and Commitment Therapy (ACT)?](https://i.ytimg.com/vi/PmKEvlv9Cys/default.jpg)
![The science of cells that never get old | Elizabeth Blackburn](https://i.ytimg.com/vi/2wseM6wWd74/default.jpg)
![Immunotherapy Research Updates Expert Panel - NYC Immunotherapy Patient Summit 2018](https://i.ytimg.com/vi/YmlteJScUdQ/default.jpg)
![Immunotherapy and Lymphoma Treatment](https://i.ytimg.com/vi/JAlEDi2rugE/default.jpg)
![Chimeric antigen receptor CAR Technique - Creative Biolabs (Original Version)](https://i.ytimg.com/vi/HxYpz-b5a3U/default.jpg)
![Tumor Mutation Burden: Challenges and opportunities](https://i.ytimg.com/vi/FntsFLUh9Qk/default.jpg)
![STING in tumour microenvironment leads to potent & systemic tumour regression & immunity](https://i.ytimg.com/vi/UKgHI860Nvc/default.jpg)
![[Webinar] Immunotherapy for Pancreatic Cancer | Pancreatic Cancer Action Network](https://i.ytimg.com/vi/arXRKIo9blE/default.jpg)
![Introduction to Cancer Biology (Part 1): Abnormal Signal Transduction](https://i.ytimg.com/vi/jjfYQMW_nek/default.jpg)
![Immuno-Oncology: A Future Look](https://i.ytimg.com/vi/6mwK3Ylh_VU/default.jpg)
![Immuno-oncology and immunotherapy introduction](https://i.ytimg.com/vi/GRjksD-EcIs/default.jpg)
![Introduction to Immunotherapy (Immunotherapy Documentary Part I)](https://i.ytimg.com/vi/8Z0Gyv-3NL8/default.jpg)
![Chimeric Antigen Receptors: From proof of concept to widely applicable clinical research solutions](https://i.ytimg.com/vi/pv7o0hFm8Ps/default.jpg)
![The promise and limits of cancer immunotherapy](https://i.ytimg.com/vi/NhmNvZKDjJw/default.jpg)
![What’s Next in CAR T Cell Therapy with Dr. Michel Sadelain](https://i.ytimg.com/vi/s7Gi4w-sGjE/default.jpg)